This is an unethically misleading study with findings easily explained by residual confounding. Some health systems and patients have thorough record keeping. Others don't. All sorts of variables will correlate (infections, cancers, anything else tracked in medical records).
This is a really obvious issue for an international epi study. It should not have been published.
The above study is using the same processes the anti-vaxxers use -- junk epi that does not account for confounding -- to support whatever pre-conceived notions the authors have, with absurdly large effects.
If you analyze data from 15 countries and 80 different health systems, you need to use multi-level modeling or meaningful control for variation across countries and systems. The absurdly large association between Covid infection and cancer (when cancers take a long time to develop) should have been a clue as to something fishy.
These are issues that should be obvious in undergrad-level observational epidemiology. The action editor should have desk rejected this paper in <30 seconds.
Let me walk you through a really basic example as non-technical as possible. Let's say Health System A is very organized, in highly-resourced country, massively resourced health system with million-dollar donors (MGB, DF, Mayo, or whatever). They will be more likely to have exquisite record keeping. They might track Covid infections better (and in the early pandemic had good access to testing!), and they will definitely track cancer test results very well.
Then, imagine Health System B. Let's say it's in a country with much fewer resources. Let's say there's no access to Covid testing, hardly at all. And perhaps the cancer test results and other records are mostly kept on paper files, but because they're a part of an international data collection system, the data get archived every 6-12 months. The archiving is slow and imperfect.
These are just very different systems in different contexts. If you have people across all different health systems and just do a correlation between Covid infection and cancer, you will get a strong positive signal *because of record keeping* (and because of many many many other 3rd variables). Some systems will track both well. Others won't have the resources to track as closely.
This is why you also see weird large effects in anti-vax studies (see the example in the prior post in this thread). The systems with resources to provide and track vaccines also have the resources to track cancers. The anti-vaxx paper using the same flawed sorts of analyses should also be retracted; I submitted a manuscript to the journal say as much, which of course, they rejected.
Turning back to the infection-cancer article.... The article's statistical analysis section is extremely short. They don't go into any of the issues I am raising. An observational epi paper should be analytically intensive. It's rare to see such an underdeveloped analytic section (and analyses) even in papers that are not analytically challenging. You'll notice some of this section appears to be AI written or AI massaged; it could just be through Grammarly or to assist with grammar more generally (I don't personally find that offensive, just a red flag that they might not know what they're doing anlytically), but as an example, there are phrases no scientist would really use, like "The PSM process was *seamlessly integrated*... using proprietary technology protect by trade secrets." It describes the analyses in ways that are direct, superficial, and insufficient for conveying what was done.
#Shih et al study
#Covid #Cancer #HPV
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Denial is but one of several obvious defense mechanisms people use to try to block their awareness of the ongoing toll of COVID-19. There are many others.
Short-term capital also plays a role, but even that requires a large dose of defense mechanisms.
During this 12th COVlD wave, the CDC reports 1-in-3 states have "High" or "Very High" levels.
PMC estimates the proportion of residents actively infectious (prevalence):
◾️USA: 1 in 67
◾️IA: 1 in 27
◾️MI: 1 in 25
◾️IN & CT: 1 in 23
◾️ME: 1 in 21
◾️OK & SD: 1 in 17
🧵1/
On average, Americans have have 5.0 cumulative SARS-CoV-2 infections.
This week's infections are expected to result in 1/4 to 1 million new #LongCOVID conditions and ≈2,000 excess deaths.
🧵2/
The wave peak is now estimated >10% higher than last week at 1.2 million new daily infections, nearly double the Delta wave.
We expect sustained high transmission (≈600,000 to 750,000 new daily infections) the next few weeks as COVlD circulates through schools/families.
🧵3/
Based on today's CDC & Biobot data, we estimate the following for the week of Jan 19:
🔸1 in 52 people in the U.S. actively infectious
🔸25% chance of exposure in a room of 15 ppl
🔸Nearly 1 million new daily infections
🔸5 cumulative infections per person all-time (avg)
🧵1/5
Transmission estimates have been marginally corrected upward.
11 states have Very High COVlD levels:
🔸PA: 1 in 25 estimated actively infectious
🔸MI: 1 in 23
🔸OH & KY: 1 in 22
🔸SD: 1 in 20
🔸NE & IA: 1 in 18
🔸IL & ME: 1 in 17
🔸IN: 1 in 16
🔸WV: 1 in 11
🧵2/5
We're in the middle of a 12th COVlD wave.
The peak has likely passed, but with students headed back to school, transmission is expected to remain high for at least the next several weeks.
The size of the winter COVlD wave has been revised upward as post-holiday data come in.
We estimated 1 in 55 people in the U.S. are actively infectious.
🔥WV: 1 in 14
🔥IN: 1 in 15
🔥MI & OH: 1 in 21
🔥MO: 1 in 22
🔥CT: 1 in 24
🔥KS: 1 in 25
🔥MA & IL: 1 in 27
Quick 🧵 1/4
Nationally, we are seeing an estimated 892,000 new daily SARS-CoV-2 infections, meaning a 1 in 4 chance of exposure in a room of 15 people. Risk varies considerably by state.
We are approaching an average of 5 infections per person since pandemic onset.
🧵 2/4
We are in the 12th COVlD wave of the U.S.
Current transmission is higher than 68% of all days since the pandemic onset in 2020.
🧵 3/4
You might not have heard, but the northeastern U.S. is in a COVlD surge.
We use wastewater levels to derive estimates of the proportion of people actively infectious in each state (prevalence), e.g., 1 in 24 people in Connecticut.